Retinopathy of Prematurity Market is Projected to Grow by 2036 Owing to the Increasing Adoption of Anti-VEGF Therapies and Emerging Treatment Approaches

The market dynamics for Retinopathy of Prematurity (ROP) are expected to witness steady growth, driven by the increasing incidence of the condition among preterm infants, rising screening and diagnosis rates,

Read More

Osteogenesis Imperfecta Market Osteogenesis Imperfectased to Grow from USD 30 Million in 2023 to USD 500 Million by 2034 as First Targeted Therapies Near Approval

(Albany, New York) – October 13, 2026: DelveInsight’s “Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast – 2034” report offers an in-depth understanding of Osteogenesis Imperfecta, historical and forecasted epidemiology, as

Read More

Ewing Sarcoma Epidemiology Forecast Through 2036 Now Available, Reports DelveInsight

Ewing sarcoma is a malignant small round cell tumor characterized by specific genetic fusions, primarily affecting bones and soft tissues in children and young adults. It most commonly presents during

Read More

Age-Related Macular Degeneration Market Valued at USD 9,840 Million in 2021, Set for Further Growth Through 2034Age-Related Macular Degeneration Market

AMD is characterized by progressive degeneration of the macula, the central part of the retina, and can be classified as early, intermediate, or late based on clinical features including drusen,

Read More

Frost & Sullivan Released the 2026 Global Gene Therapy Industry Development Blue Book

Shanghai, China – October 12, 2026 – Frost & Sullivan officially released the 2026 Global Gene Therapy Industry Development Blue Book in October 2026, in collaboration with industry partners. The report

Read More

The Product Two Brothers With Type 1 Diabetes Wanted For Themselves Is Now Helping Others Stay Prepared

Florida, US – October 12, 2026 – Level Up, a USA-made glucose beverage created by brothers Asher Shashaty and Tiras Shashaty, is offering a new approach to carrying glucose wherever life

Read More

15-year-old Chinese pianist Yidi Ding performs at Chinese consulate in New York, connecting young musicians through music

New York, USA – October 12, 2026 – The Chinese Consulate General in New York hosted “Youth, Dialogue, Future,” a U.S.-China youth choral concert, on the evening of Oct. 8.

Read More

Freight Forwarding Market to Hit USD 776.04 Billion by 2031, Says Mordor Intelligence

Freight Forwarding Market Size and Share | Mordor Intelligence Mordor Intelligence has published a new report on the freight forwarding market, offering a comprehensive analysis of trends, growth drivers, and

Read More

Pigeon Pea Market Size to Reach $9.50 Billion by 2031, Driven by Plant-Based Proteins Demand & East African Exports – Mordor Intelligence

Pigeon Pea Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the pigeon pea market, offering a comprehensive analysis of market trends, growth drivers,

Read More

Syngas Market Size to Reach 552.65 million Metric Normal Cubic Meters per Hour by 2031, Driven by Methanol Demand and Low-Carbon Hydrogen Production

Syngas Market Trends A new report from Mordor Intelligence on the “Syngas Market Size” provides an in-depth analysis of current trends, key growth factors, and upcoming opportunities. Hyderabad, October 12,

Read More

MailMyCard Launches Handwritten Cards Posted Worldwide

A handwritten MailMyCard thank-you card with its kraft envelope, written with a real pen MailMyCard, an India-based service, writes customers’ messages with a real pen on cardstock and posts them

Read More

Myositis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Roche, Pfizer, Zydus Group, Lupin, Bausch Health, Accord Healthcare, Genentech

(Albany, New York) – October 12, 2026: As per DelveInsight’s assessment, globally, Myositis pipeline constitutes 40+ key companies continuously working towards developing 45+ Myositis treatment therapies, analysis of Clinical Trials,

Read More

Metastatic Castration Resistant Prostate Cancer Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Telix Pharma, Merck, Orion Pharma, Exelixis

(Albany, New York) – October 12, 2026: As per DelveInsight’s assessment, globally, Metastatic Castration Resistant Prostate Cancer Pipeline constitutes 75+ key companies continuously working towards developing 75+ Metastatic Castration Resistant

Read More